CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Med, Dev Officer Dana Pizzuti sold $503K of Crinetics Pharmaceuticals, Inc.
Sold$503,125
$35.00Price
14,375Shares
−71%Stake
What CRNX did after the filing
- The stock from Thu, Jan 4 close, $34.77
- +8.8%
- S&P 500, same days
- +6.9%
Measured over 30 trading days, to the Feb 16 close.
Traded Wed, Jan 3. Filed Thu, Jan 4, 11:45 AM ET, during the session. Returns use the Jan 4 close and the Feb 16 close. Not investment advice.